Quoin Pharmaceuticals, Ltd
Financing
Shares on issue
168.1M
From 3.98M in June 2024
a raise that quarter, at its price
Newest
$150.0M
S-3 of 2026-10-28. 1 prospectus supplement filed under it since.
$11.0M
Leerink Partners, agreement of 2026-11-04. No at-the-market sales on file.
Warrants
10.24M
Priced warrants: 10.24M at $10.59.
Cash
7.1 quarters
$33.2M cash on hand.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-11-04 | Public offering | not available | not available | not available | 424B5 ↗ |
| 2025-10-10 | Private placement | not available | not available | $16.6M | 8-K ↗ |
| 2024-12-20 | Public offering incl. 11.97M pre-funded, with warrants at $0.45 | 15,111,110 | $0.45 | $6.8M | 424B4 ↗ |
Also on file: a 1-for-20 reverse split, 2025-04-08 8-K ↗ · a 1-for-35 reverse split, 2025-04-09 8-K ↗